305 related articles for article (PubMed ID: 3561410)
1. Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer.
Speck NA; Baltimore D
Mol Cell Biol; 1987 Mar; 7(3):1101-10. PubMed ID: 3561410
[TBL] [Abstract][Full Text] [Related]
2. In vivo footprinting of the enhancer sequences in the upstream long terminal repeat of Moloney murine leukemia virus: differential binding of nuclear factors in different cell types.
Granger SW; Fan H
J Virol; 1998 Nov; 72(11):8961-70. PubMed ID: 9765441
[TBL] [Abstract][Full Text] [Related]
3. Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers.
Manley NR; O'Connell M; Sun W; Speck NA; Hopkins N
J Virol; 1993 Apr; 67(4):1967-75. PubMed ID: 8445718
[TBL] [Abstract][Full Text] [Related]
4. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element.
Speck NA; Renjifo B; Hopkins N
J Virol; 1990 Feb; 64(2):543-50. PubMed ID: 2104942
[TBL] [Abstract][Full Text] [Related]
5. Identification of ETS domain proteins in murine T lymphocytes that interact with the Moloney murine leukemia virus enhancer.
Gunther CV; Graves BJ
Mol Cell Biol; 1994 Nov; 14(11):7569-80. PubMed ID: 7935472
[TBL] [Abstract][Full Text] [Related]
6. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity.
Speck NA; Renjifo B; Golemis E; Fredrickson TN; Hartley JW; Hopkins N
Genes Dev; 1990 Feb; 4(2):233-42. PubMed ID: 2338244
[TBL] [Abstract][Full Text] [Related]
7. Nuclear factors that bind to the enhancer region of nondefective Friend murine leukemia virus.
Manley NR; O'Connell MA; Sharp PA; Hopkins N
J Virol; 1989 Oct; 63(10):4210-23. PubMed ID: 2778872
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-1 (NF-1) binds to multiple sites within the transcriptional enhancer of Moloney murine leukemia virus.
Reisman D
FEBS Lett; 1990 Dec; 277(1-2):209-11. PubMed ID: 2269357
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of subspecies of polyomavirus and murine leukemia virus enhancer core binding protein, PEBP2, in various hematopoietic cells.
Satake M; Inuzuka M; Shigesada K; Oikawa T; Ito Y
Jpn J Cancer Res; 1992 Jul; 83(7):714-22. PubMed ID: 1325429
[TBL] [Abstract][Full Text] [Related]
10. Two blocks in Moloney murine leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined by transient expression assays.
Feuer G; Taketo M; Hanecak RC; Fan H
J Virol; 1989 May; 63(5):2317-24. PubMed ID: 2704078
[TBL] [Abstract][Full Text] [Related]
11. DNA-binding proteins that interact with the long terminal repeat of radiation leukemia virus.
Gorska-Flipot I; Jolicoeur P
J Virol; 1990 Apr; 64(4):1566-72. PubMed ID: 2157044
[TBL] [Abstract][Full Text] [Related]
12. Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins.
Sun W; Graves BJ; Speck NA
J Virol; 1995 Aug; 69(8):4941-9. PubMed ID: 7609063
[TBL] [Abstract][Full Text] [Related]
13. A single point mutation activates the Moloney murine leukemia virus long terminal repeat in embryonal stem cells.
Grez M; Zörnig M; Nowock J; Ziegler M
J Virol; 1991 Sep; 65(9):4691-8. PubMed ID: 1870196
[TBL] [Abstract][Full Text] [Related]
14. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses.
Golemis E; Li Y; Fredrickson TN; Hartley JW; Hopkins N
J Virol; 1989 Jan; 63(1):328-37. PubMed ID: 2783259
[TBL] [Abstract][Full Text] [Related]
15. The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF.
Baum C; Itoh K; Meyer J; Laker C; Ito Y; Ostertag W
J Virol; 1997 Sep; 71(9):6323-31. PubMed ID: 9261349
[TBL] [Abstract][Full Text] [Related]
16. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
Hanecak R; Pattengale PK; Fan H
J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
[TBL] [Abstract][Full Text] [Related]
17. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses.
Ishimoto A; Takimoto M; Adachi A; Kakuyama M; Kato S; Kakimi K; Fukuoka K; Ogiu T; Matsuyama M
J Virol; 1987 Jun; 61(6):1861-6. PubMed ID: 3033317
[TBL] [Abstract][Full Text] [Related]
18. Determinants of retrovirus gene expression in embryonal carcinoma cells.
Akgün E; Ziegler M; Grez M
J Virol; 1991 Jan; 65(1):382-8. PubMed ID: 1845898
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor.
Wang S; Wang Q; Crute BE; Melnikova IN; Keller SR; Speck NA
Mol Cell Biol; 1993 Jun; 13(6):3324-39. PubMed ID: 8497254
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of suppression of the long terminal repeat of Moloney leukemia virus in mouse embryonal carcinoma cells.
Tsukiyama T; Niwa O; Yokoro K
Mol Cell Biol; 1989 Nov; 9(11):4670-6. PubMed ID: 2601693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
